Local view for "http://purl.org/linkedpolitics/eu/plenary/2015-02-11-Speech-3-933-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2015-02-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Access to medicines in the EU (debate)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20150211.64.3-933-000"2
lpv:hasSubsequent	lp_eu:2015-02-11-Speech-3-934-0002
lpv:speaker	lp:Diane James2
lpv:spoken text	"Thank you very much for your question. May I suggest you go back to your sources, because you are incorrect with the figures you gave this evening. Any drug company will tell you, whether it is a generic manufacture or coming from the academic sector, that it takes a lot longer, and that they do need the time to actually develop that. If we are going to start penalising companies when they are bringing forward therapeutic innovation, I think we have started off from the wrong position."@en1
lpv:spokenAs	member; EFDD (2014-10-20--2016-11-19)3 substitute; ENVI (2014-07-01--2016-11-19)3 unknown; United Kingdom Independence Party (2014-07-01--2016-11-19)3
lpv:unclassifiedMetadata	"Diane James (EFDD ),"1 "blue-card answer"1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph